Skip to Content
Merck

Glycerol monooleate-based nanocarriers for siRNA delivery in vitro.

Molecular pharmaceutics (2012-07-17)
Guoliang Zhen, Tracey M Hinton, Benjamin W Muir, Shuning Shi, Mark Tizard, Keith M McLean, Patrick G Hartley, Pathiraja Gunatillake
ABSTRACT

We present studies of the delivery of short interfering ribonucleic acid (siRNA) into a green fluorescent protein (GFP) expressing cell line, using lipid nanocarriers in cubic lyotropic liquid crystal form. These carriers are based on glycerol monooleate (GMO) and employ the use of varying concentrations of cationic siRNA binding lipids. The essential physicochemical parameters of the cationic lipid/GMO/siRNA complexes such as particle size, ζ otential, siRNA uptake stability, lyotropic mesophase behavior, cytotoxicity,and gene silencing efficiency were systematically assessed. We find that the lipid nanocarriers were effectively taken up by mammalian cells and that their siRNA payload was able to induce gene silencing in vitro. More importantly, it was found that the nonlamellar structure of some of the lipid nanocarrier formulations were more effective at gene silencing than their lamellar structured counterparts. The development of cationic lipid functionalized nonlamellar GMO-based nanostructured nanoparticles may lead to improved siRNA delivery vehicles.

MATERIALS
Product Number
Brand
Product Description

Glycerol mono-oleate, European Pharmacopoeia (EP) Reference Standard
Pricing and availability is not currently available.